Merrimack Pharmaceuticals Inc (MACK-Q) Profile - The Globe and Mail

Add to Watchlist Create Alerts

Real-Time Last Update

Last Sale Cboe BZX Real-Time

Volume

Merrimack Pharmaceuticals Inc

ONE BROADWAY 14TH FLOOR
CAMBRIDGE MA 02142 USA
P: 617-720-8606
http://www.merrimackpharma.com

Sectors & Indices

Sector

Industry

Employees

Profile

Merrimack Pharmaceuticals, Inc., is a biopharmaceutical company focused on the discovery, development and preparation to commercialize innovative medicines paired with companion diagnostics for the treatment of serious diseases, with a special focus on cancer. Merrimack Pharmaceuticals, Inc. is headquartered in Cambridge, Massachusetts.

Key Executives

Name	Title
Gary L. Crocker	CEO/CFO/Chairman of the Board/Chief Accounting Officer/Director/President

More from The Globe

Dividend investing has lost its mojo. Here’s why – and how to adapt

The Globe Investing Club 2024: Let the competition begin!

Here’s the real reason your Canadian stocks can’t keep up

Dow ends above 40,000 milestone, TSX also at fresh record high

number cruncher

U.S technology stocks with earnings and price momentum

Lightspeed Commerce stock soars on better-than-expected profit forecast

GameStop, AMC dive further as meme stocks rally tapers off

The close: Dow briefly hits 40,000 milestone, TSX rises on upbeat earnings